This review seeks to shed light on a relatively common but poorly understood adverse effect of radiotherapy for primary and metastatic brain or head and neck tumors.
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment.
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons.
Findings show that survival declines, recurrence increases with delays of more than 60 days.
Nasogastric tubes placed reactively or gastrostomy tubes placed prophylactically? Head and neck cancer experts weigh in on which they, and their patients, prefer to use.
A team of researchers sought to determine if BWH Tumor Classification System classified tumors more accurately than AJCC 8, and their sensitivity and specificity for predicting poor outcomes.
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Overtreatment more likely in younger, male, Hispanic or Asian patients, those with extensive lymph node surgery.